结合FAST方案与高时间分辨率动态对比增强序列的简化乳腺MRI
回顾性连续纳入120例接受乳腺MRI并活检(金标准)的女性,比较FAST方案、加入高时间分辨率动态对比增强(HTR-DCE)序列的简化方案与FULL标准方案的诊断价值。所有病灶在FAST方案均可见,HTR-DCE序列检出171/179(95.5%)病灶;强化时间(TTE)<31秒与恶性相关(OR 5.6,95%CI 3.3-20.4,p<0.0001),加入该阈值后FAST分析AUROC为0.826,较FAST方案正确重分类10.6%(19/179)病灶(p=0.0034),采集时间7分48秒 vs 13分54秒。
要点
- HTR-DCE序列可检出95.5%(171/179)的病灶。
- TTE<31秒与恶性相关(OR 5.6,95%CI 3.3-20.4,p<0.0001)。
- 简化方案AUROC 0.826,较FAST正确重分类10.6%(19/179)病灶(p=0.0034)。
核心结论
- 在FAST方案中加入HTR-DCE序列可提高诊断效能,达到FULL方案的诊断水平,同时缩短采集时间。
研究设计与样本
- 回顾性连续纳入2016年7月至2017年3月接受乳腺MRI并活检(金标准)的120例女性(平均年龄55岁,范围28-88岁),共179个病灶(良性69个、交界性7个、恶性103个)。
关键影像表现/征象
- 所有病灶在FAST方案(T1W、T2W、注射后2分钟T1W脂肪饱和序列)上均可见。
- HTR-DCE序列上171/179(95.5%)病灶被检出,并记录病灶是否可见及强化时间(TTE)。
诊断标准与关键数值
- 按BI-RADS分类,FAST方案中评为BI-RADS 3的恶性阳性预测值为27.6%(8/29),FULL方案为18.7%(3/16)。
- HTR-DCE序列早期强化(TTE<31秒)与恶性相关,OR 5.6(95%CI 3.3-20.4),p<0.0001。
- FAST分析加入TTE<31秒后AUROC为0.826,较FAST方案正确重分类10.6%(19/179)病灶,p=0.0034。
临床应用与阅片要点
- 简化方案采集时间7分48秒,FULL方案13分54秒。
- HTR-DCE序列上TTE<31秒提示恶性可能,可辅助FAST方案的病灶定性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We evaluated the diagnostic value of a high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence added to a FAST protocol.
MATERIALS AND METHODS: 120 women (mean age = 55 years (28-88)) who underwent breast MRI between July 2016 and March 2017 and in whom a biopsy was performed (i.e., gold standard) (n = 179: 69 benign, 7 borderline and 103 malignant lesions) were retrospectively and consecutively included. Two readers classified lesions according to the Breast Imaging-Reporting and Data System (BI-RADS) by reading: a FAST protocol (T1W, T2W, T1W-fat saturated 2 min after injection) and then a FULL standard protocol. Independently they determined if lesions were visible and when (Time To Enhancement (TTE)) on the HTR-DCE sequence. An Abbreviated protocol was then built using data from the HTR-DCE sequence added to the FAST protocol.
RESULTS: All lesions were visible with the FAST protocol. 171/179 (95.5%) lesions were detected by reading theHTR-DCE sequence. There were a higher number of cancers rated BI-RADS 3 (PPV of malignancy of 27.6% (8/29) in FAST versus 18.7% (3/16) FULL protocol). An early enhancement on the HTR-DCE sequence (TTE < 31 s) was associated with malignancy with an OR 5.6 (CI 95%: 3.3-20.4) (p < 0.0001). Adding a TTE < 31 s to FAST analysis (AUROC = 0.826) significantly improved lesion characterization with a diagnostic gain of 10.6% (19/179) lesions correctly reclassified (p = 0.0034) compared to FAST protocol; with shorter acquisition time (7 min 48 s versus 13 min 54 s).
CONCLUSION: Adding an HTR-DCE sequence to a FAST protocol increases diagnostic performance reaching that of the FULL protocol while reducing acquisition time.
引用
- Milon A, Vande Perre S, Poujol J, et al. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence. Eur J Radiol. 2019. PMID: 31307648. doi:10.1016/j.ejrad.2019.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。